131 related articles for article (PubMed ID: 25108211)
1. Ion channels and transporters as therapeutic targets in the pulmonary circulation.
Olschewski A; Papp R; Nagaraj C; Olschewski H
Pharmacol Ther; 2014 Dec; 144(3):349-68. PubMed ID: 25108211
[TBL] [Abstract][Full Text] [Related]
2. Endothelial and smooth muscle cell ion channels in pulmonary vasoconstriction and vascular remodeling.
Makino A; Firth AL; Yuan JX
Compr Physiol; 2011 Jul; 1(3):1555-602. PubMed ID: 23733654
[TBL] [Abstract][Full Text] [Related]
3. Special topics issue of microcirculation: ion channels and pulmonary vascular function.
Townsley MI
Microcirculation; 2006 Dec; 13(8):611-3. PubMed ID: 17085422
[TBL] [Abstract][Full Text] [Related]
4. Ion Channels in Pulmonary Hypertension: A Therapeutic Interest?
Lambert M; Capuano V; Olschewski A; Sabourin J; Nagaraj C; Girerd B; Weatherald J; Humbert M; Antigny F
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30322215
[TBL] [Abstract][Full Text] [Related]
5. Modulation of ion channels in pulmonary arterial hypertension.
Guibert C; Marthan R; Savineau JP
Curr Pharm Des; 2007; 13(24):2443-55. PubMed ID: 17692012
[TBL] [Abstract][Full Text] [Related]
6. [Upregulation/downregulation of ion channels in pulmonary hypertension].
Yamamura A
Nihon Yakurigaku Zasshi; 2016; 148(5):226-230. PubMed ID: 27803434
[No Abstract] [Full Text] [Related]
7. Existing drugs and agents under investigation for pulmonary arterial hypertension.
Sharma M; Pinnamaneni S; Aronow WS; Jozwik B; Frishman WH
Cardiol Rev; 2014; 22(6):297-305. PubMed ID: 25098201
[TBL] [Abstract][Full Text] [Related]
8. [Novel concepts in the pathobiology of pulmonary arterial hypertension].
Rosenkranz S
Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S167-9. PubMed ID: 18814087
[TBL] [Abstract][Full Text] [Related]
9. Dehydroepiandrosterone: A new treatment for vascular remodeling diseases including pulmonary arterial hypertension.
Dumas de la Roque E; Savineau JP; Bonnet S
Pharmacol Ther; 2010 May; 126(2):186-99. PubMed ID: 20206649
[TBL] [Abstract][Full Text] [Related]
10. Control of pulmonary vascular tone during exercise in health and pulmonary hypertension.
Merkus D; de Beer VJ; Houweling B; Duncker DJ
Pharmacol Ther; 2008 Sep; 119(3):242-63. PubMed ID: 18586325
[TBL] [Abstract][Full Text] [Related]
11. Cellular and molecular pathobiology of pulmonary arterial hypertension.
Humbert M; Morrell NW; Archer SL; Stenmark KR; MacLean MR; Lang IM; Christman BW; Weir EK; Eickelberg O; Voelkel NF; Rabinovitch M
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):13S-24S. PubMed ID: 15194174
[TBL] [Abstract][Full Text] [Related]
12. [The cancer paradigm in pulmonary arterial hypertension: towards anti-remodeling therapies targeting metabolic dysfunction?].
Dumas SJ; Humbert M; Cohen-Kaminsky S
Biol Aujourdhui; 2016; 210(4):171-189. PubMed ID: 28327277
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary hypertension in dialysis patients.
Kosmadakis G; Aguilera D; Carceles O; Da Costa Correia E; Boletis I
Ren Fail; 2013; 35(4):514-20. PubMed ID: 23405977
[TBL] [Abstract][Full Text] [Related]
14. The pathogenesis of pulmonary hypertension--an update.
Huber LC; Bye H; Brock M;
Swiss Med Wkly; 2015; 145():w14202. PubMed ID: 26479975
[TBL] [Abstract][Full Text] [Related]
15. Role of Rho-kinase and its inhibitors in pulmonary hypertension.
Duong-Quy S; Bei Y; Liu Z; Dinh-Xuan AT
Pharmacol Ther; 2013 Mar; 137(3):352-64. PubMed ID: 23261521
[TBL] [Abstract][Full Text] [Related]
16. Targeted therapies in pulmonary arterial hypertension.
Montani D; Chaumais MC; Guignabert C; Günther S; Girerd B; Jaïs X; Algalarrondo V; Price LC; Savale L; Sitbon O; Simonneau G; Humbert M
Pharmacol Ther; 2014 Feb; 141(2):172-91. PubMed ID: 24134901
[TBL] [Abstract][Full Text] [Related]
17. [Pulmonary hypertension in pediatric heart surgery].
Falcone N
Rev Esp Anestesiol Reanim; 2001 Dec; 48(10):462-4. PubMed ID: 11792301
[TBL] [Abstract][Full Text] [Related]
18. The pharmacological treatment of pulmonary arterial hypertension.
Frumkin LR
Pharmacol Rev; 2012 Jul; 64(3):583-620. PubMed ID: 22659328
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms controlling vascular tone in pulmonary arterial hypertension: implications for vasodilator therapy.
Cogolludo A; Moreno L; Villamor E
Pharmacology; 2007; 79(2):65-75. PubMed ID: 17148943
[TBL] [Abstract][Full Text] [Related]
20. Pediatric pulmonary arterial hypertension: current and emerging therapeutic options.
Oishi P; Datar SA; Fineman JR
Expert Opin Pharmacother; 2011 Aug; 12(12):1845-64. PubMed ID: 21609302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
